We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Rare HLA Types Slow AIDS Progression

By Biotechdaily staff writers
Posted on 18 Jul 2003
Researchers studying HIV, the virus that causes AIDS, have found that HIV adapts to the most frequent human leukocyte antigen (HLA) proteins in a population, providing a selective advantage for patients with rare HLA proteins.

Investigators at the Los Alamos National Laboratory (New Mexico, USA) and Northwestern University (Evanston, IL, USA) studied a large group of homosexual men who were enrolled in the Chicago component of the Multicenter AIDS Cohort Study, an ongoing study of the natural and treated history of thousands of men infected with HIV. More...
The extent of HIV infection, or disease progression, for each participant was determined by measuring the number of T-lymphocytes: the fewer the number of T-cells, the greater the level of HIV infection. The HLA profile of each participant was also determined.

Results of the study, which was published in the July 2003 issue of Nature Medicine, showed that those with common HLA types displayed the most severe HIV infections. Participants with rarer HLA types had less severe infections that took longer to develop.

The authors suggested that HIV adapts to the most frequent HLA types in the population, providing a selective advantage for those individuals who express rare forms.





Related Links:
Los Alamos National Laboratory
Northwestern University

New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
New
Manual Pipetting Aid
Pipette Controllers macro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The device contains specific antibodies that capture the primary biomarker of pancreatic cancer. The binding of these antibodies alters the distribution of electrical charges on the electrode surface. The sensor then translates this variation into a measurable capacitance signal (photo courtesy of Gabriella Soares / IFSC-USP)

Rapid Biosensor Detects Pancreatic Cancer Biomarker for Early Detection

Pancreatic cancer is frequently identified only after it has progressed because early disease is typically asymptomatic, and survival remains extremely poor once advanced. Conventional laboratory assays... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.